TargetDx Laboratory
Valparaiso, Indiana, United States
TargetDx Laboratory, located in Michigan City, Indiana, is a medical device company dedicated to creating a groundbreaking blood test for the early detection of Non-Small Cell Lung Cancer (NSCLC). Our test, developed using a combination of protein biomarkers and proprietary machine learning algorithms delivers a highly sensitive and specific risk assessment for early-stage lung cancer. Our choice to focus on protein markers is rooted in their ability to reflect the physiological state of tissue, giving us a real-time picture of the interplay between genetics and the environment. This focus has not only led to the discovery of novel markers linked to lung cancer but has also allowed us to validate existing markers for diagnostic use, culminating in multiple patents and research publications.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- www.targetdxlab.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of TargetDx Laboratory?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now